Development of a novel PSMA-targeting small molecule-Thorium-227 conjugate for the treatment of prostate cancer

被引：0
|
作者：
Boehnke, Niels [1 ]
Indrevoll, Bard [2 ]
Hammer, Stefanie [1 ]
Papple, Alex [2 ]
Kristian, Alexander [2 ]
Cuthbertson, Alan [2 ]
Zitzmann-Kolbe, Sabine [1 ]
机构：
[1] Bayer AG, Berlin, Germany
[2] Bayer AS, Oslo, Norway
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5440
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Comparison of a novel fluorine-18 labeled PSMA-targeting agent, CTT1057, to gallium-68 PSMA-11 in patients with prostate cancer
    Behr, Spencer
    Aggarwal, Rahul
    Flavell, Robert
    Hope, Thomas
    Gao, Kenneth
    Ravanfar, Vahid
    Seo, Youngho
    Langton-Webster, Beatrice
    Berkman, Clifford
    VanBrocklin, Henry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [42] Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies
    Daria Arbuznikova
    Matthias Eder
    Anca-Ligia Grosu
    Philipp T. Meyer
    Christian Gratzke
    Constantinos Zamboglou
    Ann-Christin Eder
    Current Oncology Reports, 2023, 25 : 1363 - 1374
  • [43] Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
    Singh, Shilpi
    Barik, Debashis
    Arukha, Ananta Prasad
    Prasad, Sujata
    Mohapatra, Iteeshree
    Singh, Amar
    Singh, Gatikrushna
    BIOMEDICINES, 2023, 11 (10)
  • [44] PRECLINICAL ACTIVITY AND SAFETY PROFILE OF JANX007, A NOVEL PSMA-TARGETING TUMORACTIVATED T CELL ENGAGER FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    DiRaimondo, Thomas
    Budimir, Natalija
    Shenhav, Simon
    Wu, Hua
    Cicchini, Vanessa
    Jocic, Renee
    Ma, Lina
    Roup, Fabrece
    Campbell, Calvin
    Caffaro, Carolina
    Aerni, Hans
    Eskiocak, Ugur
    Godfrey, Wayne
    Winter, Charles
    Nasoff, Marc
    Gibson, Neil
    Campbell, David
    Salek-Ardakani, Shahram
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1376 - A1376
  • [45] Evaluation of a Long-circulating PSMA-targeting Peptide in a Xenograft Model of Bone Metastatic Prostate Cancer.
    Lo, W.
    Huang, Y.
    Chen, M.
    Lu, A.
    Wang, S.
    Chen, L.
    Farn, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S442 - S442
  • [46] Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate
    Liu, Tiancheng
    Nedrow-Byers, Jessie R.
    Hopkins, Mark R.
    Wu, Lisa Y.
    Lee, Jeonghoon
    Reilly, Peter T. A.
    Berkman, Clifford E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3931 - 3934
  • [47] PSMA-targeted thorium-227 conjugate (PSMA-TTC) inhibits tumor growth and abnormal bone changes in the intratibial LNCaP xenograft model of bone-metastatic prostate cancer
    Schatz, Christoph
    Suominen, Mari I.
    Knuuttila, Matias
    Zitzmann-Kolbe, Sabine
    Rissanen, Jukka
    Kakonen, Sanna-Maria
    Hagemann, Urs
    Scholz, Arne
    CANCER RESEARCH, 2022, 82 (12)
  • [48] Antitumor Effects of a Novel Small Molecule Targeting PCNA Chromatin Association in Prostate Cancer
    Dillehay, Kelsey L.
    Lu, Shan
    Dong, Zhongyun
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2817 - 2826
  • [49] Targeting prostate cancer metastasis with novel small molecule agonists of EphA2
    Wang, Bingcheng
    Petty, Aaron
    CANCER RESEARCH, 2015, 75
  • [50] First-in-human study of [68Ga]Ga-AAZTA-093, a novel PSMA-targeting agent, in patients with prostate cancer
    Wang, G.
    Jin, W.
    Luo, Y.
    Wang, R.
    Zhu, L.
    Kung, H.
    Miao, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S542 - S542
12345